AN2 Therapeutics, Inc. Business Finance Contracts & Agreements

12 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Rights Agreement between AN2 Therapeutics, Inc. and Equiniti Trust Company, LLC, Dated August 15, 2024
Stock Agreements
AN2 Therapeutics, Inc.
Pharmaceuticals
DE
2024
AN2 Therapeutics, Inc. 2022 Employee Stock Purchase Plan
Equity Distribution Agreements
AN2 Therapeutics, Inc.
Pharmaceuticals
2024
AN2 Therapeutics, Inc. RSU Award Grant Notice and Agreement under 2022 Equity Incentive Plan
Equity Distribution Agreements
AN2 Therapeutics, Inc.
Pharmaceuticals
2024
Underwriting Agreement between AN2 Therapeutics, Inc. and Underwriters (Cowen, Leerink, Evercore) for Common Stock Offering
Underwriting Agreements
AN2 Therapeutics, Inc.
Pharmaceuticals
CA
2023
Common Stock Certificate of AN2 Therapeutics, Inc.
Stock Agreements
AN2 Therapeutics, Inc.
Pharmaceuticals
2022
Underwriting Agreement between AN2 Therapeutics, Inc. and Underwriters (Cowen, SVB Securities, Evercore)
Underwriting Agreements
AN2 Therapeutics, Inc.
Pharmaceuticals
CA
2022
Amended and Restated Global Health Agreement between AN2 Therapeutics, Inc. and Adjuvant Global Health Technology Fund L.P.
Investment Agreements
AN2 Therapeutics, Inc.
Pharmaceuticals
DE
2022
AN2 Therapeutics, Inc. RSU Award Grant Notice and Agreement (2022 Equity Incentive Plan)
Equity Distribution Agreements
AN2 Therapeutics, Inc.
Pharmaceuticals
2022
AN2 Therapeutics, Inc. Stock Option Grant Notice and Agreement (2022 Equity Incentive Plan)
Warrant Agreements
AN2 Therapeutics, Inc.
Pharmaceuticals
2022
AN2 Therapeutics, Inc. 2022 Equity Incentive Plan
Equity Distribution Agreements
AN2 Therapeutics, Inc.
Pharmaceuticals
DE
2022
AN2 Therapeutics, Inc. Stock Option Grant Notice and Option Agreement (Amended and Restated 2017 Equity Incentive Plan)
Stock Agreements
AN2 Therapeutics, Inc.
Pharmaceuticals
DE
2022
Amended and Restated Investors' Rights Agreement by and among AN2 Therapeutics, Inc. and Investors (March 5, 2021)
Investor Rights Agreements
AN2 Therapeutics, Inc.
Pharmaceuticals
DE
2022